Photodynamic therapy with verteporfin in mallatia leventinese

Ophthalmology

Volumn 109, Issue 2, 2002, Pages 296-301

  Dantas, Marcos A ^a   Slakter, Jason S ^a,b   Negrao, Silvana ^a   Fonseca, Roberto A ^a   Kaga, Tatsushi ^a   Yannuzzi, Lawrence A ^a  

^a EAR AND THROAT HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; FLUORESCEIN;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUSEN; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALLATIA LEVENTINESE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINAL DRUSEN; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036156260     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00927-7     Document Type: Article

References (27)

1. Linkage of autosomal dominant radial drusen (mallatia leventinese) to chromosome 2p16-21
2. Macular dystrophy of mallatia leventinese. A 25 year follow up
3. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal distrophy
4. Ultrastructural findings in autosomal dominant drusen
5. Fundus-autofluoreszenz bei patienten mit vererbten makuladystrophien, malattia leventinese, familïar dominanten und altersbedingten drusen
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin One-year results of 2 randomized trials-TAP report 1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group
7. Choroidal neovascularization in younger patients
8. Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization
9. Indocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularization
10. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial
11. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial
12. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration
13. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin
14. Photodynamic therapy of choroidal hemangioma: Two case reports
15. Photodynamic therapy: A new approach to the treatment of choroidal neovascularization secondary to age-related macular degeneration
16. Lutetium texaphyrin (Lu-Tex): A potential new agent for ocular fundus angiography and photodynamic therapy
17. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin
18. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys
19. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization
20. Verteporfin
21. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration. Results of a single treatment in a phase 1 and 2 study
22. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration. Results of retreatments in a phase I and 2 study
23. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey
24. Localization of vascular endothelial growth factor in human retina and choroid
25. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
26. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes